Clinical utility of circulating tumor cell analysis in adenocarcinoma patients

被引：0
|
作者：
de Albuquerque, A. [1 ]
Kubisch, I
Ernst, D.
Stoelzel, U.
Boese-Landgraf, J.
Stamminger, G. [1 ]
Breier, G. [2 ]
Kaul, S. [1 ]
机构：
[1] Klinikum Chemnitz, Zentrum Diagnost, Chemnitz, Germany
[2] Univ Dresden, Dresden, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [21] Circulating tumor cells: clinical validity and utility
    Luc Cabel
    Charlotte Proudhon
    Hugo Gortais
    Delphine Loirat
    Florence Coussy
    Jean-Yves Pierga
    François-Clément Bidard
    International Journal of Clinical Oncology, 2017, 22 : 421 - 430
  • [22] Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma
    Kang, Byung Ju
    Ra, Seung Won
    Lee, Kyusang
    Lim, Soyeoun
    Son, So Hee
    Ahn, Jong-Joon
    Kim, Byung Chul
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2020, 83 (01) : 61 - 70
  • [23] Utility of Circulating Tumor DNA in the Management of Patients With GI Stromal Tumor: Analysis of 243 Patients
    Arshad, Junaid
    Roberts, Ali
    Ahmed, Jibran
    Cotta, Jared
    Pico, Brian A.
    Kwon, Deukoo
    Trent, Jonathan C.
    JCO PRECISION ONCOLOGY, 2020, 4 : 66 - 73
  • [24] Clinical utility of circulating tumor cell measurement in the diagnosis of indeterminate lesions of the pancreas
    Mudan, Satvinder
    Giakoustidis, Alexandros
    Thillainayagam, Andrew V.
    Jacob, Jimmy
    Stebbing, Justin
    FUTURE ONCOLOGY, 2010, 6 (01) : 177 - 179
  • [25] Clinical utility of non-EpCAM based circulating tumor cell assays
    Austin, R. Garland
    Huang, Tony Jun
    Wu, Mengxi
    Armstrong, Andrew J.
    Zhang, Tian
    ADVANCED DRUG DELIVERY REVIEWS, 2018, 125 : 132 - 142
  • [26] Clinical Utility of Serum Tumor Markers and Circulating Tumor Cell Assays in the Treatment of Breast Cancer
    Abramson, Vandana G.
    Mayer, Ingrid A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2011, 12 (04) : 403 - 411
  • [27] Clinical Utility of Serum Tumor Markers and Circulating Tumor Cell Assays in the Treatment of Breast Cancer
    Vandana G. Abramson
    Ingrid A. Mayer
    Current Treatment Options in Oncology, 2011, 12 : 403 - 411
  • [28] Analysis of circulating tumor DNA and clinical correlates in patients with esophageal, gastroesophageal junction and gastric adenocarcinoma.
    Okamura, Ryosuke
    Kato, Shumei
    Baumgartner, Joel Micah
    Patel, Hitendra
    Leichman, Lawrence P.
    Kelly, Kaitlyn J.
    Fanta, Paul T.
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Clinical utility of circulating tumor DNA in patients with head and neck cancers.
    Onyshchenko, Mykola
    Rock, Adam
    Sila, Chad
    LaBarbera, Katie
    Rathore, Richa
    Ji, Ping
    McPhaul, Laron
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18003 - E18003
  • [30] Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma
    Xu, Melody J.
    Dorsey, Jay F.
    Amaravadi, Ravi
    Karakousis, Giorgos
    Simone, Charles B., II
    Xu, Xiaowei
    Xu, Wei
    Carpenter, Erica L.
    Schuchter, Lynn
    Kao, Gary D.
    ONCOLOGIST, 2016, 21 (01): : 84 - 94
12345